A new publication dated November 1, 2026 presents research titled "Pyeongwi-San, a Traditional Digestant, Mitigates Proton Pump Inhibitor-Induced Dyspepsia Through Gut Microbial and Cholinergic Mechanisms in Mice." The study appears in the journal Neurogastroenterology and Motility.
This publication is indexed under research relevant to secretin, an approved compound with established regulatory status. The paper's title indicates an investigation into how a traditional digestant formulation, Pyeongwi-San, interacts with gut microbial and cholinergic pathways in a mouse model of proton pump inhibitor-induced dyspepsia.
No findings, outcomes, or efficacy data from the study are detailed here beyond the title and publication information provided. Readers seeking the specific results, methodology, or conclusions of this research should consult the full text through the journal or the indexed source listing.
This entry serves to note the existence and indexing of this new publication within the scientific literature as of its stated publication date. For additional background on secretin, its approved uses, and general compound information, readers can consult the compound overview.